12:37 ETAardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuit Before October 13 Deadlineprnewswire·21 hours agoAARD+4.22%
09:03 ETShareholders who lost money in shares of acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) should contact Wolf Haldenstein Immediatelyprnewswire·2 days ago, 01:03 PMAARD+4.22%
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga_article·Aug 28 at 09:06 PMNCNA+3.26%AARD+4.22%
12:26 ETAardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadlineprnewswire·Aug 28 at 04:26 PMAARD+4.22%
14:10 ETAardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuitprnewswire·Aug 27 at 06:11 PMAARD+4.22%
17:58 ETAardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuitprnewswire·Aug 26 at 09:58 PMAARD+4.22%
12:21 ETAARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Class Actionprnewswire·Aug 24 at 04:23 PMAARD+4.22%
U.S. Stock Market Midday Update: AARD up 12.22%! IPO misleading allegations lead to class action lawsuit, legal risks intensify market volatilityPrice Alert·Aug 21 at 04:48 PMAARD+4.22%
14:32 ETLAWSUIT ALERT: Investors who lost over $100,000 with Aardvark Therapeutics, Inc. (NASDAQ: AARD) between February 2025 and May 2026, should contact the Shareholders Foundationprnewswire·Aug 20 at 06:35 PMAARD+4.22%
